Doxil® — The first FDA-approved nano-drug: Lessons learned

Cited by (1,008)

Items 801–900 of 1,008

1. Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action
   Luisa M. Russell, Margot Hultz, Peter C. Searson · 2017 · Journal of Controlled Release
2. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure
   Lingxuan Mo, Jae Geun Song, Hankyu Lee, Mengjia Zhao, Hyeon Young Kim, Yoon Ji Lee, Hyuk Wan Ko, Hyo-Kyung Han · 2017 · Nanomedicine Nanotechnology Biology and Medicine
3. Clinical translation of immunoliposomes for cancer therapy: recent perspectives
   Di Wang, Yating Sun, Yange Liu, Fanchao Meng, Robert J. Lee · 2018 · Expert Opinion on Drug Delivery
4. Nanoscale systems for local drug delivery
   Tianjiao Ji, Daniel S. Kohane · 2019 · Nano Today
5. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
   Nicola d’Avanzo, Christian Celia, Antonella Barone, Maria Carafa, Luisa Di Marzio, Hélder A. Santos, Massimo Fresta · 2020 · Advanced Therapeutics
6. Production and isolation of pharmaceutical drug nanoparticles
   Vivek Verma, Kevin Michael Ryan, Luís Padrela · 2021 · International Journal of Pharmaceutics
7. A Promising Future of Ferroptosis in Tumor Therapy
   Hui Wang, Danfeng Lin, Qianqian Yu, Zhouqi Li, Cameron Lenahan, Ying Dong, Qichun Wei, Anwen Shao · 2021 · Frontiers in Cell and Developmental Biology
8. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications
   Daniel Braatz, Mariam Cherri, Michael Tully, Mathias Dimde, Guoxin Ma, Ehsan Mohammadifar, Felix Reisbeck, Vahid Ahmadi, Michael Schirner, Rainer Haag · 2022 · Angewandte Chemie International Edition
9. Pharmaceutical liposomal delivery—specific considerations of innovation and challenges
   Taoxing Peng, Weihua Xu, Qianqian Li, Yang Ding, Yongzhuo Huang · 2022 · Biomaterials Science
10. A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
    Christopher B. Fox, Sandra J. Sivananthan, Malcolm S. Duthie, Julie A. Vergara, Jeffrey A. Guderian, Elliot Moon, David Coblentz, Steven G. Reed, Darrick Carter · 2014 · Journal of Nanobiotechnology
11. Tumour-vessel-on-a-chip models for drug delivery
    David Caballero, Sophie M. Blackburn, Mar de Pablo, Josep Samitier, Lorenzo Albertazzi · 2017 · Lab on a Chip
12. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
    Ali H. El‐Far, Soad Khalil Al Jaouni, Weikun Li, Shaker A. Mousa · 2018 · Nutrients
13. Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
    Weihua Chen, Zhen Sun, Lehui Lu · 2020 · Angewandte Chemie International Edition
14. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy
    Pyae Phyo, Xi Rong Zhao, Allen C. Templeton, Wei Xu, Jason K. Cheung, Yongchao Su · 2021 · Advanced Drug Delivery Reviews
15. New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
    Qin Ouyang, Yingcai Meng, Wenhu Zhou, Jianbin Tong, Zeneng Cheng, Qubo Zhu · 2021 · Journal of drug targeting
16. Glycosylation-mediated targeting of carriers
    Shigeru Kawakami, Mitsuru Hashida · 2014 · Journal of Controlled Release
17. Strategies for triggered drug release from tumor targeted liposomes
    Erik Oude Blenke, Enrico Mastrobattista, Raymond Michel Schiffelers · 2013 · Expert Opinion on Drug Delivery
18. Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry
    Rong Ni, Junli Zhou, Naushad Hossain, Ying Chau · 2016 · Advanced Drug Delivery Reviews
19. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small
    Puneet Tyagi, J. Anand Subramony · 2018 · Journal of Controlled Release
20. Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium( ii ) complexes
    Marta Maroto-Díaz, Benelita T. Elie, Pilar Gómez‐Sal, Jorge Pérez‐Serrano, Rafael Gómez, Marı́a Contel, F. Javier de la Mata · 2016 · Dalton Transactions
21. Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging
    Yunkun Li, Yachao Li, Xiao Zhang, Xianghui Xu, Zhijun Zhang, Cheng Hu, Yiyan He, Zhongwei Gu · 2016 · Theranostics
22. From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers
    Sarah R. MacEwan, Ashutosh Chilkoti · 2016 · Angewandte Chemie International Edition
23. Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells
    Antonietta Arcella, Sara Palchetti, Luca Digiacomo, Daniela Pozzi, Anna Laura Capriotti, Luigi Frati, Maria Antonietta Oliva, Georgia Tsaouli, Rossella Rota, Isabella Screpanti et al. · 2018 · ACS Chemical Neuroscience
24. Nanoliposomes Co-Encapsulating CT Imaging Contrast Agent and Photosensitizer for Enhanced, Imaging Guided Photodynamic Therapy of Cancer
    Hao Xu, Tymish Y. Ohulchanskyy, Artem Yakovliev, Roman Ziniuk, Jun Song, Liwei Liu, Junle Qu, Zhen Yuan · 2019 · Theranostics
25. Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation
    Yingnan Si, Seulhee Kim, Eric Zhang, Yawen Tang, Renata Jaskula‐Sztul, James M. Markert, Herbert Chen, Lufang Zhou, Margaret Liu · 2019 · Biotechnology Journal
26. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation
    Jérémie Parot, Fanny Caputo, Dóra Méhn, Vincent A. Hackley, Luigi Calzolai · 2020 · Journal of Controlled Release
27. Lipid-based microbubbles and ultrasound for therapeutic application
    Daiki Omata, Johan Unga, Ryo Suzuki, Kazuo Maruyama · 2020 · Advanced Drug Delivery Reviews
28. Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects
    Raj Kumar Thapa, Dzung Bao Diep, Hanne Hjorth Tønnesen · 2021 · Journal of Pharmaceutical Investigation
29. Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes
    Phei Er Saw, Jinho Park, Eunbeol Lee, Sukyung Ahn, Jinju Lee, Hyungjun Kim, Jinjoo Kim, Minsuk Choi, Omid Cameron Farokhzad, Sangyong Jon · 2015 · Theranostics
30. Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer
    Joshua A. McCarroll, Joann Teo, Cyrille Andre Boyer, David Goldstein, Maria Kavallaris, Phoebe A. Phillips · 2014 · Frontiers in Physiology
31. DNA Origami: Folded DNA‐Nanodevices That Can Direct and Interpret Cell Behavior
    Cathal John Kearney, Christopher R. Lucas, Fergal J. O’Brien, Carlos Ernesto Castro · 2016 · Advanced Materials
32. Multivalent Polymers for Drug Delivery and Imaging: The Challenges of Conjugation
    Mallory A. van Dongen, Casey A. Dougherty, Mark M. Banaszak Holl · 2014 · Biomacromolecules
33. Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
    Dóra Méhn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas D. Gilliland · 2017 · International Journal of Pharmaceutics
34. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin
    Jingxing Si, Xiaobao Zhao, Shan Gao, Dongsheng Huang, Meihua Sui · 2019 · International Journal of Pharmaceutics
35. Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment
    Ketao Jin, Ze-Bei Lu, Jinyang Chen, Yu‐Yao Liu, Huanrong Lan, Haiying Dong, Fan Yang, Yuanyuan Zhao, Xiaoyi Chen · 2020 · Journal of Nanomaterials
36. Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies
    Helena Freire Haddad, Jacqueline A. Burke, Evan Alexander Scott, Guillermo Antonio Ameer · 2021 · Regenerative Engineering and Translational Medicine
37. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs
    Amit Lath, Anita Rani Santal, Nameet Kaur, Poonam Kumari, Nater Pal Singh · 2022 · Biotechnology and Genetic Engineering Reviews
38. Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
    Wan Su Yun, Jeongrae Kim, Dong‐Kwon Lim, Dong‐Hwee Kim, Seong Ik Jeon, Kwangmeyung Kim · 2023 · Nanomaterials
39. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response
    Donato Cosco, Donatella Paolino, Francesco De Angelis, Felisa Cilurzo, Christian Celia, Luisa Di Marzio, Diego Russo, Nicolas Tsapis, Elias Fattal, Massimo Fresta · 2014 · European Journal of Pharmaceutics and Biopharmaceutics
40. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status
    Lumin Chen, Jihong Sun, Xiaoming Yang · 2015 · Cancer Letters
41. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
    Seyedeh Alia Moosavian, Khalil Abnous, Ali Badiee, Mahmoud Reza Jaafari · 2015 · Colloids and Surfaces B Biointerfaces
42. Methods for Implant Acceptance and Wound Healing: Material Selection and Implant Location Modulate Macrophage and Fibroblast Phenotypes
    Anuraag Boddupalli, Lida Zhu, Kaitlin M. Bratlie · 2016 · Advanced Healthcare Materials
43. Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy
    Yu-Cheng Su, Pierre‐Alain Burnouf, Kuo-Hsiang Chuang, Bing‐Mae Chen, Tian‐Lu Cheng, Steve R. Roffler · 2017 · Nature Communications
44. Biologically Inspired and Chemically Derived Methods for Glucose‐Responsive Insulin Therapy
    Michael A. VandenBerg, Matthew J. Webber · 2019 · Advanced Healthcare Materials
45. General considerations regarding the in vitro and in vivo properties of block copolymer micelle products and their evaluation
    Sakai-Kato, Kumiko, Nishiyama, Nobuhiro, Kozaki, Masato, Nakanishi, Takeshi, Matsuda, Yoshihiro, Hirano, Mai, Hanada, Hiroyuki, Hisada, Shigeru, Onodera, Hiroshi, Harashima, Hideyoshi et al. · 2015 · Journal of Controlled Release
46. Bringing Again Noble Metal Nanoparticles to the Forefront of Cancer Therapy
    Ylea Vlamidis, Valerio Voliani · 2018 · Frontiers in Bioengineering and Biotechnology
47. A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
    Mara Gonçalves, Serge M. Mignani, João Rodrigues, Helena Tomás · 2019 · Journal of Controlled Release
48. Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs
    Yen‐Ho Lai, Chih-Sheng Chiang, Chin-Hao Hsu, Hung‐Wei Cheng, San‐Yuan Chen · 2020 · Biomolecules
49. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors
    Meng Zhang, Fuqiang Zhang, Te Liu, Pu Shao, Lian Duan, Jun Yan, Xupeng Mu, Jinlan Jiang · 2020 · International Journal of Nanomedicine
50. Protein and mRNA Delivery Enabled by Cholesteryl‐Based Biodegradable Lipidoid Nanoparticles
    Li, Yamin, Jarvis, Rachel, Zhu, Kuixin, Glass, Zachary, Ogurlu, Roza, Gao, Peiyang, Li, Peixuan, Chen, Jinjin, Yu, Yingjie, Yang, Yongjie et al. · 2020 · Angewandte Chemie International Edition
51. Photoresponsive Drug Delivery Systems: Challenges and Progress
    Yang Yang, Kaiqi Long, Yuxiu Chu, Huiping Lu, Weiping Wang, Changyou Zhan · 2024 · Advanced Functional Materials
52. Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry
    Elicia Maine, Varkey Jon Thomas, James M. Utterback · 2013 · Journal of Engineering and Technology Management
53. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice
    Magda Nasr, Noha Adel Nafee, Hoda Saad, Amani Hussein Kazem · 2014 · European Journal of Pharmaceutics and Biopharmaceutics
54. Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
    Jonathan D. Ashley, Charissa J. Quinlan, Valerie A. Schroeder, Mark A. Suckow, Vincenzo J. Pizzuti, Tanyel Kiziltepe, Başar Bilgiçer · 2016 · Molecular Cancer Therapeutics
55. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond
    Javed Iqbal, Banzeer Ahsan Abbasi, Riaz Ahmad, Tariq Mahmood, Barkat Ali, Ali Talha Khalil, Sobia Kanwal, Sayed Afzal Shah, Muhammad Maqsood Alam, Hussain Badshah et al. · 2018 · Applied Microbiology and Biotechnology
56. Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma
    Элеонора Рафаиловна Переверзева, Иван Дмитриевич Трещалин, M. I. Treschalin, Diana Arantseva, Yu. V. Ermolenko, Natalya Kumskova, Olga Maksimenko, Vadim Yu. Balabanyan, J. Kreuter, Svetlana Emmanuilovna Gelperina · 2018 · International Journal of Pharmaceutics
57. Imaging-assisted anticancer nanotherapy
    Dasgupta, Anshuman, Biancacci, Ilaria, Kiessling, Fabian, Lammers, Twan · 2020 · Theranostics
58. Promising effects of nanomedicine in cancer drug delivery
    Rajesh R. Wakaskar · 2017 · Journal of drug targeting
59. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration
    Xingli Cun, Man Li, Shuying Wang, Yifei Wang, Jialing Wang, Zhengze Lu, Ruixin Yang, Xian Tang, Zhirong Zhang, Qin Shu He · 2018 · Nanoscale
60. Development of Zwitterionic Polypeptide Nanoformulation with High Doxorubicin Loading Content for Targeted Drug Delivery
    Weifeng Lin, Guanglong Ma, Zhefan Yuan, Haofeng Qian, Liangbo Xu, Elie Sidransky, Shengfu Chen · 2018 · Langmuir
61. Assemblies of Peptide‐Cytotoxin Conjugates for Tumor‐Homing Chemotherapy
    Jinqiang Wang, Shiqi Hu, Weiwei Mao, Jiajia Xiang, Zhuxian Zhou, Xiangrui Liu, Jianbin Tang, Youqing Shen · 2019 · Advanced Functional Materials
62. Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery
    Amr Hefnawy, Islam Ahmed Hamed Khalil, Kholoud K. Arafa, Marwan Emara, Ibrahim mohammed El-sherbiny · 2020 · International Journal of Nanomedicine
63. Nanotechnology for delivery of natural therapeutic substances: a review
    Saka, Raju, Chella, Naveen · 2021 · Environmental Chemistry Letters
64. Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling
    Morgan Craig, Adrianne L. Jenner, Bumseok Namgung, Luke P. Lee, Aaron J. Goldman · 2020 · Chemical Reviews
65. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
    Srinivasa Reddy Bonam, Niranjan Goud Kotla, Raghvendra Ashok Bohara, Yury A. Rochev, Thomas Joseph Webster, Jagadeesh Bayry · 2020 · Nano Today
66. Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
    Rickard Nordström, Lin Zhu, Johan Härmark, Yael Levi‐Kalisman, Erez Koren, Yechezkel Barenholz, Genia Levinton, Dimitri Shamrakov · 2021 · Pharmaceutics
67. Fisetin—In Search of Better Bioavailability—From Macro to Nano Modifications: A Review
    Joanna Szymczak, Judyta Cielecka‐Piontek · 2023 · International Journal of Molecular Sciences
68. Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond
    Yi Lin, Qiang Cheng, Tuo Wei · 2023 · Biophysics Reports
69. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
    Liu, Jie, Liu, Jinhu, Mu, Weiwei, Ma, Qingping, Zhai, Xiangyu, Jin, Bin, Liu, Yongjun, Zhang, Na · 2024 · ACS Nano
70. Current state of nanomedicine drug products: An industry perspective
    Jeffrey D. Clogston, Willard R. Foss, David Harris, Hardeep S. Oberoi, Jiayi Pan, Elaine Pu, Elisa A. Torrico Guzmán, Katrin Walter, Scott Brown, Patrick Lim Soo · 2024 · Journal of Pharmaceutical Sciences
71. Nanomedicines as a cutting-edge solution to combat antimicrobial resistance
    Raghu Solanki, Nilesh Makwana, Rahul Kumar, Madhvi N. Joshi, Ashish Patel, Dhiraj Devidas Bhatia, Dipak Kumar Sahoo · 2024 · RSC Advances
72. Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes
    Maria D. Chatzidaki, Evgenia Mitsou · 2025 · Pharmaceutics
73. The role of nanomedicine and artificial intelligence in cancer health care: individual applications and emerging integrations—a narrative review
    Samathoti Prasanthi, Rajasekhar Komarla Kumarachari, Sarad Pawar Naik Bukke, Eashwar Sai Komarla Rajasekhar, Jaiswal Ashish Ashokkumar, Zohre Eftekhari · 2025 · Discover Oncology
74. Nanomedicine as an emerging platform for metastatic lung cancer therapy
    Dalit Landesman‐Milo, Srinivas Ramishetti, Dan Peer · 2015 · Cancer and Metastasis Reviews
75. Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
    Takuya Suzuki, Masako Ichihara, Kenji Hyodo, Eiichi Yamamoto, Tatsuhiro Ishida, Hiroshi Kiwada, Hiroshi Kikuchi, Hiroshi Ishihara · 2014 · International Journal of Pharmaceutics
76. Just so stories: The random acts of anti-cancer nanomedicine performance
    Seyed Moein Moghimi, Z. Shadi Farhangrazi · 2014 · Nanomedicine Nanotechnology Biology and Medicine
77. Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications
    Jae Yoon Hwang, Zibiao Li, Xian Jun Loh · 2016 · RSC Advances
78. Nanocarriers in cancer clinical practice: a pharmacokinetic issue
    Luciana Giodini, Francesco Lo Re, Davide Campagnol, Elena Marangon, Bianca Posocco, Eva Dreussi, Giuseppe Toffoli · 2016 · Nanomedicine Nanotechnology Biology and Medicine
79. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation
    Mona Alibolandi, Khalil Abnous, Marzieh Mohammadi, Farzin Hadizadeh, Fatemeh Sadeghi, Sahar Taghavi, Mahmoud Reza Jaafari, Mohammad Ramezani · 2017 · Journal of Controlled Release
80. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment
    Michel Lopes Leite, Nicolau Brito da Cunha, Fabrício Falconi Costa · 2017 · Pharmacology & Therapeutics
81. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting
    Rui Ran, Haofei Wang, Yun Liu, Yue Hui, Qi Sun, Arjun Seth, David Wibowo, Dong Chen, Chun‐Xia Zhao · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
82. Remote Actuation of Apoptosis in Liver Cancer Cells via Magneto-Mechanical Modulation of Iron Oxide Nanoparticles
    Oleg Lunov, Mariia Uzhytchak, Barbora Smolková, Mariia Lunová, Milan Jirsa, Nora M. Dempsey, André Dias, Marlio J. C. Bonfim, Martin Hof, Piotr Jurkiewicz et al. · 2019 · Cancers
83. Strategies for improving drug delivery: nanocarriers and microenvironmental priming
    Ayesha Khalid, Stefano Persano, Haifa Shen, Yuliang Zhao, Elvin Blanco, Mauro Ferrari B, Joy Wolfram · 2016 · Expert Opinion on Drug Delivery
84. How to measure release from nanosized carriers?
    Lisa Nothnagel, Matthias Gerhard Wacker · 2018 · European Journal of Pharmaceutical Sciences
85. Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity
    Jared F. Stefanick, David T. Omstead, Tanyel Kiziltepe, Başar Bilgiçer · 2019 · Nanoscale
86. The hard protein corona of stealth liposomes is sparse
    Kasper Kristensen, Trine Bjørnbo Engel, Allan Stensballe, Jens B. Simonsen, Thomas L. Andresen · 2019 · Journal of Controlled Release
87. Oral administration of protein nanoparticles: An emerging route to disease treatment
    Samira Sadeghi, Wai Kit Lee, Shik Nie Kong, Annanya Shetty, Chester Lee Drum · 2020 · Pharmacological Research
88. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy
    Yukiya Takayama, Kosuke Kusamori, Chihiro Tsukimori, Yosuke Shimizu, Mika Hayashi, Ikumi Kiyama, Hidemasa Katsumi, Toshiyasu Sakane, Akira Yamamoto, Makiya Nishikawa · 2020 · Journal of Controlled Release
89. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
    Alessandro De Vita, Chiara Liverani, Roberto Molinaro, Jonathan Otto Martinez, Kelly A. Hartman, Chiara Spadazzi, Giacomo Miserocchi, Francesca Taraballi, Michael Evangelopoulos, Federica Pieri et al. · 2021 · Scientific Reports
90. In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
    Fredrik Kullenberg, Oliver Degerstedt, Carlemi Calitz, Nataša Pavlović, David Balgoma, Johan Gråsjö, Erik Sjögren, Mikael Hedeland, Femke Heindryckx, Hans Lennernäs · 2021 · Cells
91. Comprehensive Review on Applications of Surfactants in Vaccine Formulation, Therapeutic and Cosmetic Pharmacy and Prevention of Pulmonary Failure due to COVID-19
    Bidisha Das, Biplab Kumar, Wasefa Begum, Ajaya Bhattarai, Monohar Hossain Mondal, Bidyut Saha · 2022 · Chemistry Africa
92. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol
    Sai Prachetan Balguri, Goutham R. Adelli, Karthik Yadav Janga, Prakash Bhagav, Soumyajit Majumdar · 2017 · International Journal of Pharmaceutics
93. Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance
    Xiaohui Wei, Dima Shamrakov, Nudelman Sioma, Sivan Peretz-Damari, Einat Nativ‐Roth, Oren Regev, Yechezkel Barenholz · 2018 · ACS Omega
94. New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy
    Yiming Zhou, Zhifei Dai · 2018 · Chemistry - An Asian Journal
95. Optimized Photoactivatable Lipid Nanoparticles Enable Red Light Triggered Drug Release
    Nisha Chander, Johannes Morstein, Jan Stephan Bolten, Andrej Shemet, Pieter R. Cullis, Dirk H. Trauner, Dominik Witzigmann · 2021 · Small
96. Recent advances in liposome-based targeted cancer therapy
    Yaylali Guzin Fidan, Stela Muçaj, Selin Seda Timur, R. Neslihan Gürsoy · 2023 · Journal of Liposome Research
97. Second generation liposomal cancer therapeutics: Transition from laboratory to clinic
    Kacoli Sen, Mahitosh Mandal · 2013 · International Journal of Pharmaceutics
98. Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo
    Jonathan D. Ashley, Jared F. Stefanick, Valerie A. Schroeder, Mark A. Suckow, Nathan J. Alves, Rikio Suzuki, Shohei Kikuchi, Teru Hideshima, Kenneth Carl Anderson, Tanyel Kiziltepe et al. · 2014 · Journal of Controlled Release
99. Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine
    Velthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, Dan Peer · 2014 · Cancer Letters
100. Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice
     Ruonan Bo, Yaqin Sun, Shuzhen Zhou, Ning Ou, Pengfei Gu, Zhenguang Liu, Yuanliang Hu, Jiaguo Liu, Deyun Wang · 2017 · International Journal of Nanomedicine